SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3,107.27 |
| Enterprise Value ($M) | 3,016.63 |
| Book Value ($M) | 1,318.49 |
| Book Value / Share | 9.16 |
| Price / Book | 2.36 |
| NCAV ($M) | 733.32 |
| NCAV / Share | 5.10 |
| Price / NCAV | 4.24 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.98 |
| Current Ratio | 9.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 868.84 |
| Assets | 1,454.01 |
| Liabilities | 135.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Capital Research Global Investors | |||
| 13G/A | Baillie Gifford & Co | |||
| 13G/A | Fmr Llc | 7.08 | 41.02 | |
| 13G/A | Wellington Management Group Llp | 7.49 | 47.46 | |
| 13G/A | BlackRock, Inc. | 9.60 | 0.00 | |
| 13G/A | Biogen Inc. | 4.97 | -43.89 | |
| 13G/A | Bratton Douglas K | 4.20 | -17.85 | |
| 13G/A | Vanguard Group Inc | 7.84 | 8.92 | |
| 13G/A | Temasek Holdings (Private) Ltd | 4.90 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 259,915 | 662,971 | 39.20 | |
| 205,961 | 641,529 | 32.10 | |
| 91,699 | 430,660 | 21.29 | |
| 89,617 | 464,423 | 19.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTMX – CytomX Therapeutics, Inc. | CYTK – Cytokinetics, Incorporated |
| DAWN – Day One Biopharmaceuticals, Inc. | DSGN – Design Therapeutics, Inc. |
| DVAX – Dynavax Technologies Corporation |
Financial data and stock pages provided by
Fintel.io